Alcon's BRYTLY Redness Reliever Eye Drops Receive FDA Approval

Alcon has received FDA approval for its BRYTLY Redness Reliever Eye Drops, marking the first nonprescription eye drop in the U.S. with apraclonidine to gain such approval. This expands Alcon's over-the-counter portfolio for redness relief.